Verition Fund Management’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $661K | Buy |
27,662
+8,345
| +43% | +$199K | ﹤0.01% | 2098 |
|
|
2025
Q1 | $480K | Sell |
19,317
-6,748
| -26% | -$168K | ﹤0.01% | 2008 |
|
|
2024
Q4 | $491K | Sell |
26,065
-6,723
| -21% | -$127K | ﹤0.01% | 1898 |
|
|
2024
Q3 | $493K | Buy |
+32,788
| New | +$493K | ﹤0.01% | 1696 |
|
|
2024
Q1 | – | Sell |
-10,254
| Closed | -$346K | – | 2293 |
|
|
2023
Q4 | $346K | Sell |
10,254
-1,220
| -11% | -$41.2K | ﹤0.01% | 1319 |
|
|
2023
Q3 | $352K | Buy |
+11,474
| New | +$352K | ﹤0.01% | 1341 |
|
|
2023
Q1 | – | Sell |
-8,433
| Closed | -$326K | – | 2120 |
|
|
2022
Q4 | $326K | Buy |
8,433
+4,315
| +105% | +$167K | 0.01% | 1170 |
|
|
2022
Q3 | $219K | Buy |
+4,118
| New | +$219K | ﹤0.01% | 1864 |
|
|
2022
Q2 | – | Sell |
-49,287
| Closed | -$3.76M | – | 2361 |
|
|
2022
Q1 | $3.76M | Buy |
49,287
+16,954
| +52% | +$1.29M | 0.05% | 378 |
|
|
2021
Q4 | $1.95M | Buy |
+32,333
| New | +$1.95M | 0.01% | 619 |
|
|
2017
Q2 | – | Sell |
-6,743
| Closed | -$307K | – | 1129 |
|
|
2017
Q1 | $307K | Buy |
+6,743
| New | +$307K | 0.03% | 776 |
|